Assertion: breast cancer's receptor | /r/HasProperty | expressed in triple-negative breast cancer
Facets:
value: commonly
type: TEMPORAL
Source sentences:
text: Among other mechanisms of action, leronlimab is believed to inhibit metastasis by inhibiting the CCR5 receptor on cell surfaces, which is commonly expressed in triple-negative breast cancer.